In the BioHarmony Drug Report Database

"Preview" Icon

Fluphenazine decanoate

Prolixin Decanoate (fluphenazine decanoate) is a small molecule pharmaceutical. Fluphenazine decanoate was first approved as Prolixin Decanoate on 1982-01-01. It is used to treat psychotic disorders and schizophrenia in the USA. It is known to target D(2) dopamine receptor, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 7, D(1B) dopamine receptor, histamine H1 receptor, D(1A) dopamine receptor, and 5-hydroxytryptamine receptor 2A.

 

Trade Name

 

Prolixin Decanoate
 

Common Name

 

fluphenazine decanoate
 

ChEMBL ID

 

CHEMBL1200854
 

Indication

 

psychotic disorders, schizophrenia
 

Drug Class

 

Typical antipsychotic

Image (chem structure or protein)

Fluphenazine decanoate structure rendering